GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Shanghai Kinetic Medical Co 300326.SZ · CNY

Health Care · Shenzhen · 🇨🇳 China

Compare

6.63

+0.91%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Shanghai Kinetic Medical Co

Its shares trade on Shenzhen under the ticker 300326.SZ. It has been listed since 13 June 2012. In the fiscal year to 31 December 2025, it reported revenue of CN¥963.1m and net income of CN¥134.9m. At that date it held total assets of CN¥3.07bn and shareholders' equity of CN¥2.86bn.

Shanghai Kinetic Medical Co., Ltd. engages in the research and development, manufacture. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2012-06-13. The firm is mainly engaged in the research, development, manufacture and sale of minimally invasive interventional surgical systems for vertebroplasty, the research, development, manufacture and sale of orthopedic medical devices, such as orthopedic implants and orthopedic surgical instruments, as well as the development, manufacture and sale of drug-eluting coronary stents. The firm operates its business in domestic market.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
13 Jun 2012
Employees
1,045

Leadership

Pay as last reported

  • Mr. Chong WangChairman of the Board, General Manager, since 2020
  • Mr. Yuanping LiChief Financial Officer, Deputy General Manager, since 2017CN¥1.5m
  • Mr. Kui DingDeputy General Manager, Secretary of the BoardCN¥1.7m
  • Mr. Yiwei HuiDeputy General Manager, Director, since 2025
  • Mr. Wei LiuDeputy General Manager
  • Mr. Jinyu ZhangDeputy General ManagerCN¥1.1m
  • Mr. Wen ChenDirector
  • Mr. Shiqiang JinDirector
  • Mr. Xuewen LiuIndependent Director
  • Mr. Bin ZhangIndependent Director
  • Ms. Dingmin ZhuIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Company is headquartered in Shanghai with 1045 employees.
  • Engages in R&D, manufacture, and sale of medical devices including orthopedic implants and drug-eluting stents.
  • Operates in the domestic market within China.

Weaknesses

  • No international market presence mentioned.
  • Reliance on domestic market for business operations.
  • No information provided on financial performance or market share.

Opportunities

  • Potential growth in domestic health care sector in China.
  • Expansion into international markets for medical device sales.
  • Increasing demand for minimally invasive surgical systems and orthopedic devices.

Threats

  • Competition within the domestic health care market.
  • Regulatory changes affecting medical device manufacturing.
  • Dependence on domestic market could limit growth potential.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.